Biotage AB (publ)

Informe acción OM:BIOT

Capitalización de mercado: SEK 13.4b

Biotage Dirección

Dirección controles de criterios 3/4

El CEO de Biotage's es Torben Jorgensen, nombrado en Jan 2024, tiene una permanencia de menos de un año. posee directamente un 0.4% de las acciones de la empresa, con un valor de SEK54.75M. La antigüedad media del equipo directivo y de la junta directiva es de 3.4 años y 2.5 años, respectivamente.

Información clave

Torben Jorgensen

Chief Executive Officer (CEO)

SEK 857.0k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEO0.4%
Permanencia media de la dirección3.5yrs
Promedio de permanencia en la Junta Directiva2.6yrs

Actualizaciones recientes de la dirección

Recent updates

Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Jun 08
Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

May 21
Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Apr 28
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Mar 04
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Feb 22
Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Feb 21
Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 18
Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Feb 08
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

Jan 07
Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Dec 08
At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Oct 27
Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Jul 12
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Jun 08
An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

May 24
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 05
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Mar 12
These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 21
Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Jan 06
Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Dec 03
Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Oct 27
Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Oct 07
Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Biotage (STO:BIOT) Could Easily Take On More Debt

Sep 03
Biotage (STO:BIOT) Could Easily Take On More Debt

Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

Jul 10
Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jun 25
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

May 28
Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 23
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Mar 29
Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Mar 14
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 28
Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Feb 13
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jan 23
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Is Biotage (STO:BIOT) A Risky Investment?

Dec 10
Is Biotage (STO:BIOT) A Risky Investment?

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Nov 03
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Torben Jorgensen en comparación con los beneficios de Biotage?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

SEK 236m

Dec 31 2023SEK 857kn/a

SEK 246m

Sep 30 2023n/an/a

SEK 189m

Jun 30 2023n/an/a

SEK 216m

Mar 31 2023n/an/a

SEK 240m

Dec 31 2022SEK 817kn/a

SEK 268m

Sep 30 2022n/an/a

SEK 240m

Jun 30 2022n/an/a

SEK 228m

Mar 31 2022n/an/a

SEK 216m

Dec 31 2021SEK 732kn/a

SEK 205m

Sep 30 2021n/an/a

SEK 203m

Jun 30 2021n/an/a

SEK 187m

Mar 31 2021n/an/a

SEK 174m

Dec 31 2020SEK 2mSEK 1m

SEK 175m

Sep 30 2020n/an/a

SEK 149m

Jun 30 2020n/an/a

SEK 179m

Mar 31 2020n/an/a

SEK 201m

Dec 31 2019SEK 7mSEK 3m

SEK 187m

Sep 30 2019n/an/a

SEK 196m

Jun 30 2019n/an/a

SEK 173m

Mar 31 2019n/an/a

SEK 170m

Dec 31 2018SEK 7mSEK 3m

SEK 168m

Sep 30 2018n/an/a

SEK 175m

Jun 30 2018n/an/a

SEK 162m

Mar 31 2018n/an/a

SEK 148m

Dec 31 2017SEK 6mSEK 3m

SEK 139m

Compensación vs. Mercado: La compensación total de Torben($USD82.13K) está por debajo de la media de empresas de tamaño similar en el mercado Swedish ($USD772.87K).

Compensación vs. Ingresos: La compensación de Torben ha sido consistente con los resultados de la empresa en el último año.


CEO

Torben Jorgensen (72 yo)

less than a year

Permanencia

SEK 857,000

Compensación

Mr. Torben Jorgensen, B.Sc. serves as President at Biotage AB form January 04, 2024 and serves as its as CEO since 2024 and served as its as Interim CEO since January 04, 2024 until 2024 and served as its...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Torben Jorgensen
CEO, President & Directorless than a yearSEK 857.00k0.40%
SEK 53.8m
Andrew Kellett
Chief Financial Officerless than a yearsin datossin datos
Anders Wikstrom
Executive Vice President of Operations14.2yrssin datos0.0064%
SEK 864.3k
Raffaella Bombarda
EVP of Global Marketingno datasin datossin datos
Petra Duprez
Chief Human Resources & Sustainability Officerno datasin datos0.019%
SEK 2.5m
Scott Carr
President of Americas & Chief/Head of Americasno datasin datos0.0064%
SEK 864.3k
Jonas Stahlberg
Chief Auditorno datasin datossin datos
Olof Nord
Executive Vice President of Business Developmentno datasin datos0.025%
SEK 3.4m
Andreas Juhlin
President of International - EMEA and APAC4.1yrssin datos0.0064%
SEK 864.3k
Magnus Nordstedt
Executive Vice President of IT & Digitalizationno datasin datos0.0059%
SEK 787.7k
Lisa Egelrud
Executive Vice President of Quality Assurance & Regulatory Affairs3.5yrssin datossin datos
Maryam Poorafshar
Executive Vice President R&Dno datasin datossin datos

3.5yrs

Permanencia media

52.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de BIOT se considera experimentado (3.4 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Torben Jorgensen
CEO, President & Director4.7yrsSEK 857.00k0.40%
SEK 53.8m
Kieran Murphy
Chairman1.3yrsSEK 227.00ksin datos
Peter von Ehrenheim
Director11.3yrsSEK 407.00k0.020%
SEK 2.7m
Asa Hedin
Director4.7yrsSEK 337.00ksin datos
Mark Bradley
Director5.3yrsSEK 307.00ksin datos
Kugan Sathiyanandarajah
Director1.3yrssin datossin datos
Dan Menasco
Employee Representative Director2.6yrssin datossin datos
Karen Soerensen
Director2.3yrsSEK 357.00ksin datos
Par Lundgren
Employee Representative Directorno datasin datossin datos
Philip Lamberstam
Employee Representative Directorless than a yearsin datossin datos

2.6yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de BIOT no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.